Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia
- 31 October 1995
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 99 (4) , 362-369
- https://doi.org/10.1016/s0002-9343(99)80182-x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Lipid-Lowering Therapy and Macrovascular Disease in Diabetes MellitusDiabetes, 1992
- Coronary Heart Disease Incidence in NIDDM Patients In The Helsinki Heart StudyDiabetes Care, 1992
- George Lyman Duff Memorial Lecture. Atherogenesis in diabetes.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Lipoprotein Physiology in Nondiabetic and Diabetic States: Relationship to AtherogenesisDiabetes Care, 1991
- Trends in Prevalence of Diabetes Mellitus in Patients with Myocardial Infarction and Effect of Diabetes on Survival: The Minnesota Heart SurveyDiabetes Care, 1991
- Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease ? putative association via common antecedents; further evidence from the whitehall studyDiabetologia, 1988
- Lipids, diabetes, and coronary heart disease: Insights from the Framingham StudyAmerican Heart Journal, 1985
- Lipoprotein Composition in Individuals with Impaired Glucose ToleranceDiabetes Care, 1983
- Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham StudyDiabetes Care, 1979
- Morbidity and Mortality in Diabetics In the Framingham Population: Sixteen Year Follow-up StudyDiabetes, 1974